Diseases [C] » Urogenital Diseases [C12] » Female Urogenital Diseases and Pregnancy Complications » Pregnancy Complications » Obstetric Labor Complications
Description
Medical problems associated with OBSTETRIC LABOR, such as BREECH PRESENTATION; PREMATURE OBSTETRIC LABOR; HEMORRHAGE; or others. These complications can affect the well-being of the mother, the FETUS, or both. MeSH
Hierarchy View
Subtype Terms (12)
Abruptio Placentae
5 approved drugs
Breech Presentation
6 approved drugs
Dystocia
4 drugs (2 approved, 2 experimental)
Fetal Membranes, Premature Rupture
10 drugs (6 approved, 4 experimental)
Obstetric Labor, Premature
44 drugs (29 approved, 15 experimental)
Placenta Accreta
4 drugs (3 approved, 1 experimental)
Placenta Previa
10 approved drugs
Postpartum Hemorrhage
49 drugs (34 approved, 15 experimental)
Uterine Rupture
1 approved drug
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (4)
Phase 3 Indicated Drugs (5)
Other Experimental Indicated Drugs (3)
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (9)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Other Experimental Indications (4)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.